MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 12.70
+0.20 (1.60%)
At close: May 29, 2026
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 821.96 million as of May 29, 2026. Its market cap has increased by 30.93% in one year.
Market Cap
821.96M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.70
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 821.96M, a decrease of -61.11%. That is a compound annual growth rate of -18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 821.96M | 2.01% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.06B |
| Lukas Biomedical | 1.05B |
| GeneReach Biotechnology | 1.02B |
| U-Neuron Biomedical | 1.00B |
| TCI GENE | 976.32M |
| Taiwan Advance Bio-Pharmaceutical | 896.40M |
| NatureWise Biotech & Medicals | 895.40M |
| Neith | 833.08M |